GENEPHARM AE - søkeresultat

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

omeprazole genepharm omeprazole 20 mg tablet bottle

medis pharma pty ltd - omeprazole, quantity: 20 mg - tablet, enteric coated - excipient ingredients: ascorbyl palmitate; microcrystalline cellulose; crospovidone; lactose monohydrate; magnesium stearate; povidone; hypromellose phthalate; purified talc; triacetin; iron oxide red; iron oxide black - omeprazole tablets are indicated for: a. gastro-oesophageal reflux disease (gord): 1. symptomatic gord: the relief of heartburn and other symptoms associated with gord. 2. erosive oesophagitis: the treatment and prevention of relapse. b. peptic ulcers: 1. the treatment of duodenal and gastric ulcer. 2. combination therapy for the treatment of peptic ulcer disease associated with heliobacter pylori infection. 3. the treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs. 4. the prevention of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer. 5. long-term prevention of relapse in gastric and duodenal ulceration, in patients proven to be heliobacter pylori negative, or in whom eradication is inappropriate, e.g. the elderly, or ineffective. c. zollinger-ellison syndrome: the treatment of zollinger-ellison syndrome.